5 Unlikely Companies Bucking the Biotech Sell-Off
The SPDR S&P Biotech ETF is down 22.4% over the trailing month, but these five biotech stocks are all up. What's their secret?
Shorts Are Piling Into These Stocks. Should You Be Worried?
Do short-sellers have these three stocks pegged? You be the judge!